0 0.0 0.0 00-Week Non-Controlled Double-Blind Trial Adverse Events Reported in > 0% of Patients and More Commonly in Patients Treated with Pioglitazone Hydrochloride 00 mg + Insulin than in Patients Treated with Pioglitazone Hydrochloride 00 mg + Insulin % of Patients Pioglitazone Hydrochloride 00 mg + Insulin N=000 Pioglitazone Hydrochloride 00 mg + Insulin N=000 Hypoglycemia 0